ABVC BioPharma, Inc. (ABVC)
1.00
+0.02
(+2.04%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Free Cash Flow : -2.697M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.697M |
| March 31, 2026 | -3.346M |
| December 31, 2025 | -2.992M |
| September 30, 2025 | -2.646M |
| June 30, 2025 | -1.621M |
| March 31, 2025 | -0.9385M |
| December 31, 2024 | -1.354M |
| September 30, 2024 | -1.693M |
| June 30, 2024 | -2.635M |
| March 31, 2024 | -3.291M |
| December 31, 2023 | -4.208M |
| September 30, 2023 | -4.264M |
| June 30, 2023 | -3.879M |
| March 31, 2023 | -6.580M |
| December 31, 2022 | -7.758M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| September 30, 2021 | -9.963M |
| June 30, 2021 | -6.760M |
| March 31, 2021 | -6.757M |
| December 31, 2020 | -6.042M |
| September 30, 2020 | -3.50M |
| June 30, 2020 | -4.271M |
| March 31, 2020 | -3.396M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.308M |
| September 30, 2019 | -2.711M |
| June 30, 2019 | -2.483M |
| March 31, 2019 | -2.267M |
| December 31, 2018 | -2.255M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | -2.825M |
| September 30, 2016 | -3.475M |
| June 30, 2016 | -3.266M |
| March 31, 2016 | -0.4296M |
| December 31, 2015 | -0.875M |
| September 30, 2015 | -0.0007M |
| June 30, 2015 | -0.0678M |
| March 31, 2015 | -0.0702M |
| December 31, 2014 | -0.0702M |
| September 30, 2014 | -0.0702M |
| June 30, 2014 | -0.0001M |
| March 31, 2014 | -0.0002M |
| December 31, 2013 | -0.0014M |
| September 30, 2013 | -0.0378M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 0.562M |
| Perspective Therapeutics, Inc. | -121.38M |
| MiMedx Group, Inc. | 42.33M |
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -3.873M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.2444M |
| Cash from Investing (Quarterly) | -0.1015M |
| Cash from Financing (Quarterly) | 0.2262M |
| Free Cash Flow Per Share (Quarterly) | -0.0094 |
| Free Cash Flow to Equity (Quarterly) | -0.4006M |
| Free Cash Flow to Firm (Quarterly) | -0.2021M |
| Free Cash Flow Yield | -10.81% |